Meeting
2018 ASCO Annual Meeting
Cervical microbiome role in outcomes of therapeutic HPV vaccination for cervical intraepithelial neoplasia.
Authors
Rahul Ravilla
University of Arkansas for Medical Science, Little Rock, AR
Rahul Ravilla , Hannah Coleman , Luisa Chan , Cheryl-Emiliane Chow , Barbara Fuhrman , William Greenfield , Michael Scott Robeson , Kathryn Iverson , Horace J Spencer , Mayumi Nakagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics and Translational Research
Sub Track
Vaccines
Clinical Trial Registration Number
NCT01653249
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3099)
DOI
10.1200/JCO.2018.36.15_suppl.3099
Abstract #
3099
Poster Bd #
313
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
First Author: Mayumi Nakagawa
First Author: Thanuja Neerukonda
Poster
2023 ASCO Annual Meeting
Efficacy and safety of combining PD-1 blockage and human papillomavirus vaccine for patients with relapsed/refractory advanced cervical cancer.
First Author: Buhai Wang
Poster
2022 ASCO Annual Meeting
Human papillomavirus (HPV) vaccine hesitancy trends in the United States.
First Author: Eric Adjei Boakye